etabolic syndrome (MetS), defined as a cluster of ≥3 disorders that include insulin resistance, dyslipidemia, hypertension, hypercholesterolemia, and abdominal obesity, 1,2 is associated with the risk of developing type 2 diabetes mellitus, coronary heart disease, stroke, and cardiovascular-related mortality. 3,4 MetS affects >20% of adults in Western populations. However, given the acculturation of Western diet in the developing world, the burden of MetS is highly prevalent worldwide. Although insulin resistance is generally accepted as the main underlying pathogenic mechanism, increasing evidence links excessive reactive oxygen species (ROS) production and tissue oxidative stress to the pathogenesis of MetS and the progression of its complications. 5,6 A recent cross-sectional study reported that subjects with more MetS components exhibit higher levels of oxidative stress. 7 Better understanding of the significance of the redox signaling in MetS is therefore warranted. The brain uses large amounts of oxygen and ATP for its normal functions and is therefore highly susceptible to oxidative stress. Reports on brain oxidative stress in the pathogenesis of MetS, however, are sporadic. Of the few studies reported, oxidative stress in the hypothalamus is involved in the progression of obesity-induced hypertension. 8 In the rostral ventrolateral medulla (RVLM), where sympathetic premotor neurons reside, 9 oxidative stress induces sympathoexcitation in rats with obesity-induced hypertension.
Hypertension
October 2014 dinucleotide phosphate (NADPH) oxidase and mitochondrial respiratory enzymes play pivotal roles in neural mechanism of hypertension. In addition, uncoupling of nitric oxide synthase (NOS) contributes to the increased ROS production in cerebral microvessels. 15 Intriguingly, NOS dysfunction is implicated in hypertension of individuals with MetS. 16 The significance of the interplay between NOS and ROS in RVLM in MetS-associated hypertension is currently unknown.
Normotensive rat fed a high-fructose diet (HFD) is a wellestablished rodent model for the study of human MetS. This model mimics several features, including hypertension, insulin resistance, and abnormal lipid profile, of patients with MetS induced by Western diet. 17, 18 Using this MetS model, we sought to identify the source of ROS and its interplay with NOS in RVLM on neural mechanisms of hypertension associated with MetS.
Materials and Methods
All experimental procedures were performed in compliance with the guidelines of Institutional Animal Care and Use Committee in Kaohsiung Chang Gung Memorial Hospital or Kaohsiung Veterans General Hospital. They were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Detailed Materials and Methods are described in the onlineonly Data Supplement.
Adult (8 weeks of age) male Sprague-Dawley rats (235-296 g; n=136) purchased from the Experimental Animal Center of the National Applied Research Laboratories, Taiwan, were used. Animals were acclimatized for 1 week in an Association for Assessment and Accreditation of Laboratory Animal Care International-accredited animal facility during which they had free access to commercial rat chow. Rats were subsequently divided randomly into 2 groups to receive either normal diet (ND; containing 46% complex carbohydrate, 3.4 kcal/g; Harlan Laboratories, Madison, WI) or HFD (60% fructose diet, 3.6 kcal/g; TD.89247, Harlan). The assigned diets were offered ad libitum for 8 weeks. Within the ND and HFD groups, animals were further divided randomly into the following groups to receive additional treatments for 2 weeks, beginning on week 6 after the initiation of ND or HFD: (1) oral intake of the insulin sensitizer, 19 pioglitazone (20 mgkg ), or artificial cerebrospinal fluid. A third group of animals received microinjection bilaterally into RVLM, nucleus tractus solitarii (NTS), or hypothalamic paraventricular nucleus (PVN) of a lentiviral vector (Lv) carrying small hairpin RNA (shRNA) on week 6 to silence protein inhibitor of neuronal NOS (nNOS; PIN; Lv-PIN shRNA, 1×10 6 pfu/80 nL). The dose of test agents used was adopted from previous studies 12, 22, 23 or determined in the pilot study. In each experimental group, the levels of fasting plasma glucose, insulin, and triglycerides were determined before, every week, and at the end of 8 weeks of ND or HFD. The presence of insulin resistance was determined by calculating the homeostatic model assessment of insulin resistance indices, and glucose intolerance was determined by the oral glucose tolerance test. Arterial pressure was measured before and weekly after ND or HFD treatment under conscious condition by radiotelemetry. Sympathetic vasomotor outflow from RVLM was assessed by the power density of the low-frequency (LF) component of the systolic blood pressure spectrum. 24 At various time intervals after the commencement of ND or HFD treatment, animals were killed with an overdose of pentobarbital sodium (100 mg/kg, IV), and both sides of RVLM were removed for assessment of tissue ROS, nitric/nitrite (NOx), or tetrahydrobiopterin levels; protein expression of insulin receptor (InsR), NADPH oxidase subunits, NOS isoforms, monomer or homodimer of nNOS, PIN, SOD isoforms, or GTP cyclohydrolase I (GTPCH I); as well as enzyme activity of the NADPH oxidase, mitochondrial electron transport chain (ETC) enzymes, SOD, or NOS.
Statistical Analysis
All values are expressed as means±SEM. One-way or 2-way ANOVA with repeated measures was used to assess group means, as appropriate, to be followed by the Scheffé multiple-range test for post hoc assessment of individual means. The Student t test was used to compare the means of 2 groups. P<0.05 was considered statistically significant.
Results

HFD Increases Sympathetic Vasomotor Activity and Blood Pressure
Compared with the ND group, mean arterial pressure obtained from radiotelemetry was significantly increased in animals that received HFD for 8 weeks (Figure 1 ). This was accompanied by an increase in the power density of the LF component of the systolic blood pressure spectrum. It was noted that those changes became significant on week 4 and lasted for the remainder of the HFD treatment period. At the same time, the ), delivered to the animals on week 6 after HFD treatment.
Animals that received HFD for 8 weeks manifested major characteristics of MetS, including hyperinsulinemia, insulin resistance, hypertriglyceridemia, and glucose intolerance ( Figure S1 in the online-only Data Supplement). These traits were significantly ameliorated by oral intake of pioglitazone (20 mgkg ) for 2 weeks beginning on week 6 after HFD treatment. Pioglitazone treatment, however, elicited minimal effect on the same parameters in the ND-fed animals (data not shown). Pioglitazone treatment also inhibited the increase in protein expression of InsR in RVLM measured on week 8 after HFD feeding ( Figure S1) 
Oxidative Stress in RVLM of HFD-Fed Rats
The HFD-induced hypertension was accompanied by increased tissue level of ROS in RVLM (Figure 2A ), which became significant on week 4 and endured the remainder of the HFD treatment period. This increase in ROS level in RVLM, detected on week 8 after HFD treatment, was significantly blunted by oral intake of pioglitazone (20 mgkg ), delivered to the animals on week 6 after HFD treatment. Feeding animals with HFD for 8 weeks significantly reduced the activity of nicotinamide adenine dinucleotide cytochrome c reductase (marker enzyme for electron transport capacity between ETC-I and ETC-III) and cytochrome c oxidase (marker enzyme for ETC-IV) to be reversed by pioglitazone or CoQ 10 treatment ( Figure 2B ). CoQ 10 also significantly alleviated the augmented mitoSOX immunoreactivity in RVLM neurons of HFD-fed rats ( Figure S2 ) and phox (C), or superoxide dismutase (SOD) 1, SOD2, or SOD 3 (D), or nicotinamide adenine dinucleotide phosphate (NADPH) oxidase or SOD activity (E) detected from rostral ventrolateral medulla on week 4, 6, or 8 after animals were subjected to normal diet (ND) or high-fructose diet (HFD) treatment, alone or with additional oral intake of pioglitazone (20 Figure 2C ) or SOD isoforms ( Figure 2D ), and enzyme activity of NADPH oxidase or SOD ( Figure 2E ) in RVLM, detected on week 4 or 8 after HFD treatment.
Reduced Tissue NOx Level and Augmented NOS Expression in RVLM of HFD-Fed Rats
The tissue level of NOx in RVLM was decreased on weeks 4 and 8 after HFD treatment and was restored by oral intake of pioglitazone (20 Figure 3A ). The protein expression of nNOS, but not endothelial or inducible NOS, in RVLM was significantly increased during the same intervals ( Figure 3B ), which was significantly attenuated in HFD-fed animals when subjected to the same scheme of pioglitazone or tempol treatment ( Figure 3C ).
Increased Redox-Sensitive nNOS Uncoupling and Overexpression of PIN in RVLM of HFD-Fed Rats
The dimer-to-monomer ratio, an indicator of NOS coupling, 25 was significantly decreased in RVLM of rats subjected to HFD treatment for 8 weeks (Figure 4A ), alongside a significant increase in PIN expression, a protein that ) starting on week 6 after diet treatment. Values are mean±SEM of quadruplicate analyses on samples pooled from 6 to 8 animals in each group. *P<0.05 vs ND group and inhibits nNOS activity 26 ( Figure 4B ). Oral treatment with pioglitazone (20 mgkg −1 day −1 ) or intracisternal infusion of tempol (100 pmolkg −1 day −1 ) during the past 2 weeks of HFD diet attenuated both molecular events. Enzyme activity of total NOS in RVLM was significantly reduced in HFD-fed rats ( Figure 4C ) and was restored after pioglitazone or tempol treatment.
No Change in Tissue Level of Tetrahydrobiopterin or GTPCH I Expression in RVLM of HFD-Fed Rats
NOS can become uncoupled when tetrahydrobiopterin is deficient. 27 In animals subjected to 8 weeks of HFD treatment, there was no significant change in tissue level of tetrahydrobiopterin ( Figure 5A ). Furthermore, the expression of GTPCH I, the rate-limiting enzyme in the synthesis of tetrahydrobiopterin, 28 was comparable between the HFD and ND groups ( Figure 5B ). Neither tetrahydrobiopterin nor GTPCH I expression was affected by microinjection bilaterally into RVLM of Lv-PIN shRNA to silence PIN mRNA expression.
Gene Knocking Down of PIN in RVLM Restores NOS Activity and Promotes Antihypertension in HFD-Fed Rats
We further elucidated the functional significance of NOS/ ROS interplay at RVLM in HFD-induced cardiovascular phenotypes using PIN gene knockdown. On week 6 after HFD treatment, microinjection bilaterally into RVLM of Lv-PIN shRNA (1×10 6 pfu/80 nL; Figure S3 ), but not an shRNA randomer (Lv-PIN scrambled RNA) known not to block any mammalian mRNA, promoted antihypertension and reduced the augmented power density of the LF component of systolic blood pressure spectrum that lasted for ≥2 weeks ( Figure 6A ). These were accompanied by restoration of nNOS dimerization ( Figure 6B ), tissue NOx level ( Figure 6C ), and amelioration of the enhanced ROS accumulation in RVLM ( Figure 6D ), when detected on week 8 after HFD treatment. Microinjection into the bilateral RVLM of Lv-PIN shRNA significantly decreased PIN mRNA and protein expression in RVLM of both NDand HFD-fed rats ( Figure S4 ). The same treatment, however, exerted no effect on protein expression of the 3 NOS isoforms in RVLM of HFD-fed rats (data not shown).
Site-Specific Effect of PIN on NOS Activity in RVLM and Antihypertension in HFD-Fed Rats
In addition to RVLM, we also measured tissue levels of ROS and NOx in NTS and PVN, 2 major autonomic nuclei in central cardiovascular regulation. 29 HFD feeding for 8 weeks augmented tissue level of ROS but reduced NOx level in NTS and PVN ( Figure 7A ), with no significant change in protein expression of PIN in both nuclei ( Figure 7B ). Furthermore, bilateral microinjection of Lv-PIN shRNA into NTS or PVN on week 6 after HFD treatment exerted no apparent effect on the induced pressor responses ( Figure 7C ).
Discussion
The present study revealed that rats subjected to HFD for 8 weeks developed MetS-associated increase in sympathetic vasomotor tone and neurogenic hypertension. In RVLM of these rats, there was an increase in tissue ROS accumulation that resulted from nNOS uncoupling via upregulation of PIN and depression of mitochondrial ETC capacity. However, protection against oxidative stress rescued the reduced NOS activity in RVLM; gene silencing PIN mRNA expression restored NOx content and ameliorated oxidative stress in RVLM. Both treatments also reversed the overdrive of sympathetic vasomotor tone and promoted antihypertension in HFD-fed animals. Together, our results provide evidence to suggest a novel underlying mechanism for hypertension in MetS, which involves NOS uncoupling and an aberrant interplay between NOS and ROS in RVLM, resulting in oxidative stress-associated activation of central sympathetic vasomotor outflow.
MetS is closely associated with dysfunction of the autonomic nervous system. Patients with this syndrome manifest increased sympathetic nerve activity 30, 31 and high concentration of urine or plasma catecholamine. 32 Based on HFD-fed rats, an experimental model of human MetS, 17, 18 we found in the present study that the sympathetic vasomotor outflow from RVLM, as reflected by the power density of the LF component of systolic blood pressure spectrum, 12, 24, 33 was significantly increased, alongside the pressor response. These data complement the reported increase in plasma level of norepinephrine after the HFD 34 and provide additional evidence of sympathoexcitation in the MetS. These findings are also in concert with previous reports 8, 10, 35 on augmented central sympathetic outflow from RVLM in obesity-induced hypertension, a condition often observed in patients with MetS.
Mechanistically, our data indicated that oral intake of an insulin sensitizer, pioglitazone, reversed HFD-induced hyperinsulinemia and insulin resistance (cf Figure S1 ), as well as blunted sympathoexcitation and hypertension (cf Figure 1) . These results suggest that the latter responses are associated with HFD-induced peripheral hyperinsulinemia, although a potential central effect of this insulin sensitizer in RVLM cannot be excluded. Circulating insulin can cross the blood-brain barrier through transport-mediated uptake mechanism 36 or directly activate InsRs in brain areas that contain highly permeable capillaries that lack a specific transport mechanism. 37 Consistent with a previous study, 38 we found that low-level InsRs expression was present in RVLM, which was significantly increased in a pioglitazone-reversible manner after HFD treatment (cf Figure S1 ). Although providing a molecular basis for the suggested role of insulin, exactly how InsRs in RVLM are activated after HFD treatment and the insulinrelated signaling that contributes to sympathoexcitation, nevertheless, remained to be determined. Toward this end, blockade of glutamatergic receptors in RVLM reverses sympathoexcitation and increase in blood pressure during shortterm (120 minutes) hyperinsulinemia. 38 It is also noteworthy that although administration of insulin into the brain ventricular system increases sympathetic neural outflow, 39 a bolus microinjection of insulin into RVLM does not increase lumbar sympathetic nerve activity or blood pressure. 38 Therefore, the possibility of an excitatory projection from the forebrain insulin-responsive regions, such as the arcuate nucleus 40 and PVN, 41 to RVLM on sympathoexcitation and hypertension during hyperinsulinemia cannot be overlooked in this model of MetS. Activation of tissue renin-angiotensin system is seen in human and animal models of MetS and diabetes mellitus. 42 A cross-talk between the InsR and angiotensin receptors, as in the endothelial and vascular smooth muscle cells, 43 further underscores the importance of the renin-angiotensin system in the development of endothelial dysfunction and arterial We 44, 45 and others 13, 14 reported previously that oxidative stress in RVLM mediates sympathoexcitation seen in neurogenic hypertension. We found in the present study that the tissue level of ROS in RVLM was significantly increased in HFD-fed animals. That pioglitazone treatment significantly abrogated the enhanced ROS in RVLM (cf Figure 2) indicates that oxidative stress in RVLM is a consequence of hyperinsulinemia. The attenuation of HFD-induced sympathoexcitation and hypertension by intracisternal infusion of an effective antioxidant dose of tempol (cf Figure 2) further suggests a contributing role for oxidative stress at RVLM in neurogenic hypertension associated with MetS. The lack of effect by tempol treatment on traits of MetS (cf Figure S1 ) provides evidence to deem unlikely a direct action of this antioxidant on overall insulin metabolism. We reported previously 22 that oral intake of rosiglitazone, an insulin-sensitizing thiazolidinedione agent structurally similar to pioglitazone, 46 alleviates oxidative stress in RVLM of the spontaneously hypertensive rats via upregulation of mitochondrial antioxidant uncoupling protein 2. The role of this mitochondrial antioxidant in HFD-induced oxidative stress in RVLM awaits further elucidation. We recognize that oxidative stress in RVLM also mediates obesity-induced hypertension. 8, 10, 35 Nevertheless, we found in the present study that HFD treatment for 8 weeks did not result in weight gain, as reported in this model of MetS. 34 Extension of HFD feeding to 12 (J.Y.H. Chan et al., unpublished data, 2014) or 20 weeks 47 also did not cause a significant increase in body weight. We therefore reason that it is unlikely that the relationship between oxidative stress in RVLM and development of hypertension in this HFD model of MetS is obesity-dependent.
The cellular sources of ROS in RVLM include increase in NADPH oxidase subunit expression and enzyme activity, 10 reduction in mitochondrial ETC activity, 11 and downregulation of SOD. 23 We demonstrated in the present study that mitochondrial dysfunction because of a decrease in electron transport capacity between ETC complexes I and III, as well as complex IV (cf Figure 2) , plays a predominant role in ROS generation in RVLM and hypertension under conditions of HFD-induced MetS. This notion is commensurate with the finding that electron transport between complexes I and III in the ETC is a primary source of superoxide anion production. 48 The notion that deficiency in mitochondrial ETC capacity underpins HFD-induced oxidative stress in RVLM is further consolidated by the observation that intracisternal infusion of CoQ 10 , a mobile electron carrier between complexes I and III or II and III, 21 preserved nicotinamide adenine dinucleotide cytochrome c reductase and cytochrome c oxidase activity (cf Figure 2 ) and significantly blunted the augmented mitochondrial ROS (cf Figure S2 ) and pressor response in HFD-fed rats. However, our results demonstrated that NADPH oxidase and SOD antioxidant systems might not play an active role. Both protein expression and enzyme activity of the NADPH oxidase and SOD (cf Figure 2) are not affected after 8 weeks of HFD treatment. Because tempol or CoQ10 was administered via chronic intracisternal infusion, redox signaling in other autonomic nuclei in the brain stem, such as NTS and caudal VLM, in HFD-induced hypertension cannot be ruled out.
It is known that NOS isoforms in an uncoupled state produce ROS and decrease NO bioavailability. 49 The discrepancy in our finding of reduced tissue NOx levels (cf Figure 3) and increased nNOS protein expression (cf Figure 3) in RVLM of HFD-fed rats prompted us to speculate that nNOS uncoupling is responsible for the generation of ROS, although uncoupling of endothelial NOS or inducible NOS in RVLM cannot be excluded. The most prominent cause for NOS uncoupling is loss of the critical cofactor tetrahydrobiopterin, the bioavailability of which is regulated by the enzyme GTPCH I. 27, 28 This mechanism, however, may not be applicable in RVLM after HFD treatment. We found that both tissue level of tetrahydrobiopterin and protein expression of GTPCH I were not affected by HFD treatment (cf Figure 5) . Alternatively, our data indicate that upregulation of PIN may underlie nNOS uncoupling and the generation of ROS. PIN is an 89-amino-acid protein that inhibits nNOS activity by binding to this NOS isoform to impede its dimerization. 50 Stability of homodimer is critical for functional nNOS activity, 27 and PIN destabilizes the enzyme homodimer formation 26, 50 by binding to the contact region in the oxygenase domain. 51 When PIN level is increased, the homodimer structure is altered such that electrons normally flowing from the reductase domain to the oxygenase domain of the enzyme are diverted to molecular oxygen rather than to the substrate l-arginine. 52 Under these conditions, the catalytic activity becomes functionally uncoupled, and superoxide rather than NO is produced. It is noteworthy that in RVLM of HFD-fed rats, there is a significant decrease in dimer/monomer ratio that is negatively correlated with PIN upregulation (cf Figure 4) , as well as the decrease in NOS activity and tissue NOx level. Furthermore, stabilizing nNOS dimer formation by silencing the PIN gene (cf Figure 6 ) resulted in the restoration of tissue NOx level and a significant reversal of the augmented ROS level in RVLM of HFD-fed rats (cf Figure 6 ). All these molecular events leading to nNOS uncoupling and the decrease in NOS activity are found to be protected by treatments with pioglitazone, tempol, or CoQ 10 . Thus, it is likely that an abnormal amount of insulin may be the driving force that instigates a vicious cycle of mitochondrial ROS generation, upregulation of PIN, nNOS uncoupling, and inhibition of NOS activity, leading to further ROS production in RVLM of HFD-fed rats (Figure 8 ). Impaired NO signaling because of nNOS uncoupling and oxidative stress was recently observed in the cerebral artery of Zucker obese rats 53 and in penile arteries under conditions of insulin resistance. 54 PIN was demonstrated in a recent study 55 to decrease the catalytically active dimeric nNOS via ubiqutin-dependent proteolytic degradation of the enzyme in the brain. Whether this modification of nNOS activity by PIN contributes to ROS generation under the condition of MetS awaits further investigation.
The role of PIN in neural regulation of blood pressure is unknown. To our knowledge, the present study is the first to identify a role for PIN in central cardiovascular regulation and the development of redox-mediated neurogenic hypertension associated with MetS. We found that suppression of PIN expression in RVLM by Lv-PIN shRNA resulted in antihypertension and reversal of sympathoexcitation in rats with established MetS. Systemic injection of the small interfering RNA against PIN was recently reported to decrease arterial pressure in spontaneously hypertensive rats. 56 We noted that silencing the PIN gene in RVLM only partially reversed the increased ROS production (an average of 24%), sympathetic activation (an average of 28%), and the induced hypertension (≈35%) in HFD-fed rats, although the treatment almost completely reversed PIN upregulation (cf Figure S4) and restored tissue NOx level (cf Figure 6) . These results are interpreted to suggest that PIN-mediated NOS uncoupling in RVLM only partially contributes to the redox-associated hypertension during MetS.
We found in the present study that in addition to RVLM, tissue levels of NO and ROS in NTS and PVN were also affected by HFD treatment; generation of ROS was increased, whereas NO production was decreased in all these nuclei. It is thus conceivable that perturbation of ROS and NO homeostasis in major brain autonomic areas may represent a unified mechanism that contributes to the pressor response associated with MetS. Nevertheless, we found that PIN expression was not significantly altered after HFD treatment and gene silencing of PIN in NTS, or PVN exerted no effect on the induced pressor response (cf Figure 7) . Speculatively, these results suggest that site-specific mechanisms that underpin the HFD-induced interplay between NO and ROS exist in different autonomic nuclei. In this regard, an ROS-dependent inhibition of NO production via suppression of nNOS phosphorylation in NTS was recently reported 34 to mediate hypertension induced by the HFD.
In conclusion, the present study reveals that hyperinsulinemia after HFD feeding triggers a vicious cycle of mitochondrial redox-associated and PIN-mediated NOS uncoupling, leading to exacerbation of ROS rather than NO production in RVLM. This aberrant interplay between NOS and ROS contributes to the sustained oxidative stress in RVLM, resulting in sympathoexcitation and neurogenic hypertension in MetS (Figure 8 ).
Perspectives
Global prevalence of MetS is rapidly on the rise. In addition to the more classical causes, several phenomena, including oxidative stress, leptin resistance, and inflammation, have been proposed during the past decade to be key pathophysiological mechanisms contributing to the increase in cardiovascular risk Figure 8 . Schematic diagram illustrating the molecular events that take place in rostral ventrolateral medulla (RVLM), leading to sympathoexcitation and hypertension after high-fructose diet (HFD). HFD treatment induces hyperinsulinemia that reduces mitochondrial electron transport capacity. Mitochondrial oxidative stress upregulates protein inhibitor of neuronal nitric oxide synthase (eNOS; PIN) expression that inhibits dimerization of nNOS, resulting in nNOS uncoupling despite an increase in its protein expression. This redox-sensitive and PIN-mediated NOS uncoupling exacerbates reactive oxygen species (ROS) production in RVLM and results in sympathoexcitation and hypertension associated with HFD-induced metabolic syndrome. ETC indicates electron transport chain. that affect MetS patients. 3 Our findings of an aberrant interplay between NOS and ROS in the brain and the role of oxidative stress at RVLM in neural mechanism of hypertension in MetS may thus open a new and highly intriguing research vista in the field. Stemming from our study is the notion that hyperinsulinemia and insulin resistance are at the center of several signaling pathways that lead to intensification of oxidative stress. As such, defining the molecular and cellular pathways that link insulin resistance and brain oxidative stress shall significantly advance the mechanistic understanding on both the development of MetS and its consequential cardiovascular complications. Restoration of NOS activity by counteracting oxidative stress may be a novel therapeutic strategy for hypertension in MetS. CoQ supplement was reported to be beneficial to the management of metabolic disorders associated with obesity. 57 Our finding that CoQ 10 ameliorates the aberrant interplay between NOS and ROS and alleviates oxidative stress in RVLM of HFD-fed animals provides evidence to support the potential usefulness of CoQ 10 in the treatment of MetS with hypertension. 
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• High-fructose diet-induced hyperinsulinemia upregulates protein inhibitor of neuronal NOS expression to instigate NOS uncoupling and ROS, rather than NO, generation in RVLM.
• Restoration of NOS activity by gene silencing the protein inhibitor of neuronal NOS mRNA counteracts oxidative stress and ameliorates sympathoexcitation and hypertension associated with metabolic syndrome.
What Is Relevant?
• Metabolic syndrome is associated with heightened sympathetic activity.
Oxidative stress in RVLM leads to sympathoexcitation and hypertension.
• Our study provided evidence for insulin-dependent and protein inhibitor of neuronal NOS-mediated NOS uncoupling at RVLM in redox-sensitive hypertension in metabolic syndrome. 
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ROLE OF NOS UNCOUPLING AT ROSTRAL
Arterial Pressure Measurement by Radiotelemetry
Arterial pressure (AP) and heart rate (HR) were measured in rats under conscious conditions using a radiotelemetry system (Data Sciences International, Minneapolis, MN) according to previously reported procedures. 1, 2 For the implantation of radiotelemetry receiver, rats were anesthetized with sodium pentobarbital (50 mg/kg, IP). A flexible catheter attached to a telemetry transmitter (Data Sciences International) was inserted into the abdominal aorta immediate below the renal arteries and secured in place with surgical glue. The transmitter was secured to the abdominal muscle and remained in the abdominal cavity for the duration of the experiment. The skin was closed using non-absorbable suture, and rats were returned to individual cages positioned over an RLA-3000 radiotelemetry receiver (Data Sciences International).
Animals routinely received procaine penicillin (1,000 IU, IM) injection postoperatively to prevent infection. They were allowed to recover from surgery for 7 days before the commencement of AP recording. Only animals that showed progressive weight gain after the operation were used for the experiments. The averaged mean AP (MAP) recorded 60 minutes every day between 14:00 and 15:00 was used as the daily value.
Power Spectral Analysis of Arterial Pressure Signal
The AP recorded via radiotelemetry was analyzed by an arterial blood pressure analyzer (Notocord, Croissy-Sur-Seine, France) to obtain systolic blood pressure (SBP). Continuous, on-line and real-time auto-spectral analysis (Notocord) of SBP signals based on Fourier transform was used to detect temporal fluctuations in the low-frequency (LF; 0.25-0.8 Hz) band, the power density of which was used as our experimental index for sympathetic vasomotor tone.
3,4
Metabolic Parameter Measurement Animals were sacrificed for collection of blood samples at various time intervals after the beginning of ND or HFD treatment. Blood collected was centrifuged at 1000 × g for 15 minutes to separate serum. Plasma glucose, insulin or triglyceride concentration was determined with a glucose oxidase kit (Sigma, St Louis, MI), an insulin ELISA kit (Alpco Diagnostics, Salem, NH), or a triglyceride kit (Sigma). The insulin and glucose concentrations were used to calculate the 'homeostasis model assessment' (HOMA) indices of insulin resistance (IR) according to formulas described elsewhere. 5 For oral glucose tolerance test (OGTT), rats were given a glucose load of 2 g/kg as 40% glucose solution via oral garvage after an overnight 12-hour fast, and blood glucose concentrations was measured at 30, 60, 90, and 120 minutes after oral glucose administration. The glucose concentrations during OGTT were evaluated from the total areas under the serum glucose curve using the trapezoidal method. Daily food intake was measured throughout the study. To determine body fat mass, retroperitoneal (epididymal plus perirenal) fat pads were excised and weighed immediately after euthanasia at the end of the study.
Osmotic Minipump Implantation
After obtaining baseline AP for at least 3 days using radiotelemetry, animals were anesthetized with pentobarbital sodium (50 mg/kg, IP) for the implantation of osmotic minipump. 2 A midline dorsal neck incision was made, and the dura mater between the foramen magnum and C1 lamina was exposed following dissection of muscles. The dura was perforated with a 22-gauge steel needle, and a PE-10 catheter (Clay Adams, Sparks, MD) was advanced for 5 mm into the cisterna magna. Drainage of cerebrospinal fluid (CSF) from the outer end of catheter ensured patency of the implantation. The catheter was sealed to the dura with tissue glue and the incision was closed with layered sutures. The outer end of the catheter was connected to a micro-osmotic minipump (Alzet 1007D; Durect Co., Cupertino, CA), which was placed under the skin in the neck region. Animals received procaine penicillin (1,000 IU, IM) injection postoperatively, and only animals that showed progressive weight gain after the operation were used in subsequent experiments. Test agents used for intracisternal infusion included a superoxide dismutase mimetic, Lentiviral Gene Production and Titration pLVX-IRES-tdTomato vector with validated small hairpin RNA (shRNA) for PIN mRNA or control vector was packaged into viral particles in HEK293K cell using the Lenti-X™ HT Packaging System (Clontech, Mountain View, CA). These plasmids were transfected into 50-70% confluent 293T cells using Xfect TM polymer (Clontech) according to the user manual's protocol. The lentiviral particles were harvested from media at 48 hours, and concentrated with the Lenti-X concentrator (Clontech). The lentiviral titer was determined by the Lenti-X qRT-PCR Titration kit (Clontech) to a titer of 10 9 viral particles per milliliters.
Microinjection of Lentivirus into the Brain Nuclei
Microinjection bilaterally of the Lv-PIN shRNA, randomer (Lv-PIN scRNA) or Lv-green florescence protein (Lv-GFP; as a control vector) was carried out stereotaxically and sequentially into RVLM, NTS or PVN of rats that were anesthetized with sodium pentobarbital (50 mg/kg, IP). After reaching an adequate plane of anesthesia (unresponsive to paw pinch and no corneal withdrawal reflex) animals were placed into a stereotaxic head holder (Kopf, Tujunga, CA) on a thermostatically controlled heating pad. Microinjection bilaterally of the viral vectors was carried out with a glass micropipette (external tip diameter: 50-80 m) connected to a 0.5-l Hamilton microsyringe. [1] [2] [3] [4] For RVLM microinjection, a total of eight injections (4 on each side) of undiluted virus (80 nL total volume) were made at two rostro-caudal levels at stereotaxic coordinates of 4.5-5.0 mm posterior to lambda, 1.8-2.1 mm lateral to the midline, and 8.0-8.5 mm below the dorsal surface of cerebellum. These coordinates cover the confines of RVLM within which sympathetic premotor neurons reside. 8 For NTS microinjection, a total of four injections (one on each side) of 80 nL of undiluted virus were made at two rostro-caudal levels. The coordinates for the NTS were 4.5-5.0 mm from the interaural bars, 0.3-1.0 mm lateral to the midline, and 0.5-0.8 mm below the dorsal surface of the medulla. 9 For PVN microinjection, the procedures were the same as for RVLM microinjection. The coordinates for the PVN were 1.5-1.8 posterior to the bregma, 0.4-0.6 mm lateral to the midline, and 7.5-7.8 mm below the surface of the parietal dura. 10 After in vivo lentivirus injection, the wound was closed in layers and animals were allowed to recover in individual cages with free access to food and water.
Tissue Sample Collection
At various time intervals after the diet or treatment, animals were killed with an overdose of pentobarbital sodium (100 mg/kg, IP) and perfused intracardially with warm saline. The brain was rapidly removed and immediately frozen on dry ice. The medulla oblongata covering RVLM or NTS was blocked between 0.5 and 1.5 mm rostral to the obex, which was adopted from the atlas of Watson and Paxinos 11 and served as the anatomical landmark. Both sides of the ventrolateral or dorsomedial medulla, covering RVLM (approximately 1.5-to 2.5-mm lateral to the midline and medial to the spinal trigeminal tract) or NTS (approximately 1.0-mm lateral to the midline at the level of the obex), were collected by micropunches with a 1-mm inner diameter burr. [1] [2] [3] [4] 9 The hypothalamic region covers the PVN was sliced into 200-μm thick coronal sections in a cryostat. The PVN was dissected via micropunch under a microscope. Medullary and hypothalamic tissues collected from the same experimental groups were pooled and stored at -80°C.
Protein Extraction
Total protein from RVLM, NTS or PVN was extracted with ice-cold lysis buffer.
Protease inhibitors (10 g/ml aprotinin, 10 g/ml leupeptin and 20 g/ml phenylmethylsulfonyl fluoride) and phosphatase inhibitors (2 mM NaF, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate) were included in the lysis buffer to prevent protein degradation. Solubilized proteins were centrifuged at 20,000 × g at 4C for 15 minutes, and proteins in the supernatant were quantified by the Bradford assay with a protein assay kit (Bio-Rad, Hercules, CA).
Western Blot Analysis
Proteins (50 g) were separated using 7.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to PVDF membrane for 1.5 hours at 4°C, using a Bio-Rad miniprotein-III wet transfer unit. The transfer membranes were then incubated with blocking solution (5% nonfat dried milk dissolved in Tris-buffered saline-Tween buffer (pH 7.6, 10 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween 20) for 1 hour at room temperature. 
Measurement of Tissue Reactive Oxygen Species
For measurement of the reactive oxygen species (ROS) in the brain tissues, extracted proteins were reacted with the oxidation-sensitive fluorescent probe dihydroethidium (DHE, 1 μM; Invitrogen). 
Measurement of Tissue NOx Level
Tissues of RVLM, NTS or PVN were dissected, frozen in liquid nitrogen, and homogenized in lysis buffer. After centrifugation in 20,000 × g at 4C for 15 minutes, the supernatant was deproteinized using a Centricon-30 filtrator (Microcon YM-30, Bedford, MA) and stored at -80C until further processing. The level of total nitrate and nitrite (NOx) was determined with the purge system of a nitric oxide analyzer (Sievers NOA 280 TM , Boulder, CO) based on chemiluminescence reaction. 12 All assays were performed in quadruplicate and expressed as nmol/mg protein.
Measurement of Tetrahydrobiopterin level
Tissue level of tetrahydrobiopterin (BH 4 ) was measured using a BH 4 ELISA kit (MyBioSource; San Diego, CA) which utilizes a monoclonal anti-BH 4 antibody and a BH 4 -HRP conjugate. The sample and buffer were incubated together with BH 4 -HRP conjugate in pre-coated plate for one hour, followed by incubation with a substrate for HRP enzyme. A stop solution was then added to stop the reaction. The intensity of color was measured spectrophotometrically at 450 nm in a microplate reader (FluorStar). A standard curve was plotted and the BH 4 concentration in each sample was interpolated from this standard curve. All assays were performed in quadruplicate and expressed as pg/mL.
Measurement of NADPH Oxidase Activity
NADPH oxidase activity of protein samples from RVLM was measured using the lucigenin-derived chemiluminescence method. 13 The luminescence assay was performed in phosphate buffer, containing 1 mM EGTA, 150 mM sucrose and 5 M lucigenin as the electron acceptor, and 100 M NADPH as the substrate. After dark adaptation, background counts were recorded and a tissue homogenate (100 g protein) was added. The chemiluminescence value was recorded at 30-s intervals over 10 min. Superoxide production was measured after the addition of NADPH (100 μM) into the incubation medium as a substrate in the absence and presence of a flavoprotein inhibitor of NADPH oxidase, diphenyleneiodonium (10 μM). To minimize interference by light, all measurements were conducted in the dark room with temperature maintained at 22-24C. Light emission was recorded by a Sirius Luminometer (Berthold, Germany). Protein concentrations were determined using a Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA). Data are presented as relative light units/min/mg protein.
Measurement of Superoxide Dismutase Activity
The activity of SOD in samples from RVLM was measured using a SOD assay kit (Calbiochem). 3 This assay kit utilizes 5,6,6a,11b-tetrahydro-3,9,10-trihydroxybenso[c]fluorine as the substrate. This reagent undergoes alkaline autoxidation, which is accelerated by SOD, and yields a chromophore that absorbs maximally at 525 nm. The SOD activity was measured according to manufacturer's instructions. Specific activity was expressed as U/mg protein.
Measurement of Nitric Oxide Synthase Activity
NOS activity in RVLM was measured using a NOS activity assay kit (Calbiochem  , Merck KGaA). In brief, RVLM tissue was homogenized in phosphate buffered saline (pH 7.4), and centrifuged at 10,000 × g for 20 minutes. This was followed by ultracentrifuging the supernatant at 100,000 × g for 15 minutes and filtrating the supernatant through a 0.45 µm filter. The filtrate was used for measurement of NOS activity according to manufacturer's instructions. Absorbance was read at 540 nm using a microplate reader (FluorStar).
Isolation of Mitochondrial Fraction from RVLM
The mitochondrial fraction from RVLM tissue was isolated following procedures reported previously. 3 RVLM tissue homogenate was centrifuged at 13,500 × g for 10 minutes, and the pellet was used to isolate mitochondrial protein by discontinuous Percoll gradient centrifugation. This procedure yields 10-15% of the total mitochondria, and enriches the mitochondrial fraction by at least 10-fold. The purity of the mitochondrial-rich fraction was verified by the expression of the mitochondrial respiratory enzyme complex IV, cytochrome c oxidase. Total protein in the mitochondrial extract was estimated by the method of Bradford with a protein assay kit (Bio-Rad).
Mitochondrial Respiratory Enzymes Activity Assay
Activities of mitochondrial respiratory chain enzymes were measured immediately after mitochondrial isolation, according to procedures reported previously 3,14 using a thermostatically regulated ThermoSpectronic spectrophotometer (Fisher Scientific UK, Loughborough, UK). Enzyme activity was expressed in nmol/mg protein/min.
For measurement of nicotinamide adenine dinucleotide (NADH) cytochrome c reductase (NCCR; marker enzyme for MR-I and MRC-III) activity, the mitochondrial fraction (20 g of protein) was incubated in a mixture containing 50 mM K 2 HPO 4 buffer, pH7.4, 1.5 mM KCN, 1 mM -NADH, 20 M rotenone at 37C for 2 minutes. After the addition of 0.1 mM cytochrome c, the reduction of oxidized cytochrome c was measured as the difference in the presence or absence of rotenone at 550 nm for 3 min at 37C. The molar extinction coefficient of cytochrome c at 550 nm is 18,500 M/cm.
Determination of succinate cytochrome c reductase (SCCR; marker enzyme for MRC-II and MRC-III) activity in the mitochondrial fraction (30 g) was performed in 40 mM K 2 HPO 4 buffer (pH 7.4), 1.5 mM KCN, supplemented with 20 mM succinate.
After a 5-min equilibration at 37C, 50 M cytochrome c was added and the reaction was monitored at 550 nm for 3 minutes at 37C. The cytochrome c oxidase (CCO, marker enzyme for MRC-IV) activity was measured by oxidation of the reduced cytochrome c. The activity is defined as the first-order rate constant and is calculated from known concentration of ferrocytochrome c and the enzyme amount in the assay mixture. Mitochondria fraction (30 g) and 500 mM K 2 HPO 4 (pH7.4) was pre-incubated at 30°C for 5 minutes. A 45 M ferrocytochrome c was added to start the reaction monitored at 550 nm for 3 minutes at 30C. The background rate was measured after the addition of 1.0 M K 3 Fe(CN) 6 .
Double Immunofluorescence Staining and Laser Confocal Microscopy
On week 8 after ND or HFD treatment, the brain stem was removed from animals after they were killed by an overdose of sodium pentobarbital (100 mg/kg, IV), and fixed in 30% sucrose in 10% formaldehyde-saline solution for  72 hours. The procedures for double immunofluorescence staining were modified form those reported previously. 2, 4 In brief, free-floating 30-m sections of the medulla oblongata containing the RVLM were incubated with a rabbit polyclonal antiserum against PIN (1:100; BD biosciences), together with a mouse monoclonal antiserum against NeuN 
Histology
With the exception of animals used for biochemical analyses, the brain stem was removed from animals after they were killed by an overdose of sodium pentobarbital (100 mg/kg, IV), and fixed in 30% sucrose in 10% formaldehyde-saline solution for  72 hours. Frozen 25-m sections of the medulla oblongata were stained with 1% Neural Red for histological verification of the location of microinjection sites.
Statistical Analysis
All values are expressed as means ± SEM. One-way or 2-way analysis of variance with repeated measures was used to assess group means, as appropriate, to be followed by the Scheffé multiple-range test for post hoc assessment of individual means. In some cases, Student's t-test was used. P < 0.05 was considered statistically significant. Values are mean  SEM of quadruplicate analyses on samples pooled from 5-6 animals in each group. *P < 0.05 versus ND group, and # P < 0.05 versus HFD group in the post hoc Scheffé multiple range analysis. Scale bar: 20 m.
